ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $24,000 | +4.3% | 13,439 | -2.1% | 0.00% | – |
| Q2 2016 | $23,000 | 0.0% | 13,733 | +16.9% | 0.00% | – |
| Q1 2016 | $23,000 | -73.6% | 11,748 | -37.4% | 0.00% | – |
| Q2 2015 | $87,000 | -11.2% | 18,759 | -16.6% | 0.00% | – |
| Q1 2015 | $98,000 | +18.1% | 22,494 | -5.5% | 0.00% | – |
| Q4 2014 | $83,000 | -23.1% | 23,815 | -7.5% | 0.00% | – |
| Q3 2014 | $108,000 | -29.9% | 25,740 | +5.2% | 0.00% | – |
| Q1 2014 | $154,000 | +10.8% | 24,474 | +2.9% | 0.00% | – |
| Q4 2013 | $139,000 | +14.9% | 23,790 | +3.7% | 0.00% | – |
| Q3 2013 | $121,000 | -56.0% | 22,934 | -35.8% | 0.00% | -100.0% |
| Q2 2013 | $275,000 | – | 35,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
| DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
| SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
| Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
| FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
| GAM Holding AG | 523,164 | $997,000 | 0.02% |
| STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |